🇺🇸 FDA
Pipeline program

probiotic strain Bb-12

2008-01852

Phase 3 other completed

Quick answer

probiotic strain Bb-12 for Infections, Respiratory is a Phase 3 program (other) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
Infections, Respiratory
Phase
Phase 3
Modality
other
Status
completed

Clinical trials